AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Noxopharm Obtains $1.8 Million in Funding Ahead of R&D Rebate
September 09, 2024 02:19 PM AEST| By Team Kalkine MediaNoxopharm Ltd,(ASX:NOX),has secured $1.8 million in advanced funding through a secured loan agreement with Endpoints Capital Pty Ltd, a specialist in R&D finance for the life sciences sector. This loan is backed by an anticipated rebate from the Aust...
CSL Ltd and Pro Medicus Limited: Current Performance and Key Insights
September 09, 2024 01:53 PM AEST| By Team Kalkine MediaAs the year progresses, CSL Ltd and Pro Medicus Limited are making significant strides in their respective sectors. CSL Ltd, an,ASX healthcare stock,, has experienced a notable rise in its share price, reflecting its robust position in the biotechnol...
Exploring the Latest Developments in RMD Shares
September 06, 2024 04:06 PM AEST| By Team Kalkine MediaResMed CDI has been on a remarkable upward trajectory in 2024, with its share price surging 42.6% since the start of the year. Investors are taking a keen interest in RMD shares,(ASX:RMD),, and several factors are contributing to this impressive perf...
Breakthroughs in Coronary Disease Indicate Potential Future Reduction in Deaths
September 06, 2024 02:47 PM AEST| By Team Kalkine MediaCoronary disease remains the leading cause of death in Australia, accounting for about 24% of all fatalities. While the World Health Organisation estimates that approximately 17.9 million people worldwide succumb to coronary diseases annually, recent...
Orthocell Products Enter Canadian Market with Initial Sale via Partner BioHorizons
September 06, 2024 02:21 PM AEST| By Team Kalkine MediaOrthocell Ltd,(ASX: OCC,), has advanced its global market expansion by making its debut in the Canadian biotech sector with the first sale of its products through distribution partner BioHorizons. This milestone marks a significant step in Orthocell’...
Immuron Receives Positive Feedback from US FDA Ahead of IMM-529 Investigational New Drug Application
September 06, 2024 02:20 PM AEST| By Team Kalkine MediaImmuron Ltd,(ASX:IMC),has received positive feedback from the United States Food and Drug Administration (FDA) regarding its IMM-529 product, aimed at preventing or treating Clostridioides difficile infection (CDI). This feedback follows a pre-IND (I...
Biotron Ltd (ASX:BIT) Faces Backlash Over Disappointing COVID Drug Trial Results
September 06, 2024 01:34 PM AEST| By Team Kalkine MediaBiotron Ltd,(ASX:BIT),is under scrutiny following the results of its latest trial for its COVID-19 drug, BIT225-012. The trial results, which were eagerly anticipated, have not met the expectations of shareholders and have been met with frustration o...
Pacific Smiles CEO Andrew Vidler Steps Down Amid Company Transition
September 06, 2024 11:53 AM AEST| By Team Kalkine MediaPacific Smiles Group Ltd,(ASX:PSQ),, a prominent player in the dental industry, has announced the resignation of its Chief Executive Officer, Andrew Vidler. The company revealed that Vidler will fulfill a six-month notice period before officially ste...
Orthocell Expands Global Reach with Collagen-Based Dental Bone Repair Product in Canada
September 06, 2024 10:39 AM AEST| By Team Kalkine MediaOrthocell (ASX:OCC) has achieved another milestone with its collagen-based bone repair product, Striate+, as the company confirms initial sales in Canada. This marks a significant step in Orthocell’s ongoing global expansion, following successful mar...
CLEO Diagnostics Launches Major Ovarian Cancer Blood Test Trials in the U.S.
September 06, 2024 10:02 AM AEST| By Team Kalkine MediaCLEO Diagnostics (ASX:COV) has embarked on significant U.S.-based trials aimed at assessing the reliability and effectiveness of its ovarian cancer-detecting blood tests. The tests are intended to identify ovarian cancer in its early stages, marking...
Race Oncology Finalizes Board Overhaul to Advance Next Growth Phase
September 04, 2024 05:21 PM AEST| By Team Kalkine MediaRace Oncology Ltd,(ASX: RAC),has reached a significant milestone in its strategic development, completing a comprehensive board renewal process aimed at strengthening its leadership team for future growth. The company has appointed Dr. Peter Smith as...
Lumos Diagnostics Adds Tenmile Ventures as New Shareholder
September 04, 2024 05:19 PM AEST| By Team Kalkine MediaLumos Diagnostics Holdings Ltd,(ASX:LDX),is raising A$10 million through a pro rata accelerated non-renounceable entitlement offer, with the retail component underwritten up to approximately A$6 million. The offer has generated significant interest,...
The Transformative Impact of Regenerative Medicine on Healthcare
September 04, 2024 05:15 PM AEST| By Team Kalkine MediaRegenerative medicine is revolutionizing health care by focusing on repairing, replacing, or regenerating damaged or diseased cells, tissues, or organs to restore normal function. This emerging field integrates biology, engineering, and clinical prac...
Lumos Diagnostics Gains Twiggy Forrest as Key Investor in $10M Raise
September 04, 2024 05:12 PM AEST| By Team Kalkine MediaEmerging companies Lumos Diagnostics, Memphasys, and Vitura Health are making notable strides in their respective sectors. From advancing diagnostic technologies to revolutionizing fertility solutions and expanding telehealth services, these,ASX heal...
Lumos Diagnostics Wins Twiggy Forrest as Major Investor
September 04, 2024 12:56 PM AEST| By Team Kalkine MediaIn today's market updates, Lumos Diagnostics aims to raise $10 million to advance its diagnostic technology, while,ASX healthcare stock,Memphasys ventures into the equine fertility sector with its innovative sperm-selection device. Vitura Health also...
Noxopharm Targets Challenging Brain Cancer with New Developments
September 03, 2024 04:17 PM AEST| By Team Kalkine MediaThis week, several,ASX-listed healthcare stocks,made headlines with notable updates. Noxopharm Ltd achieved promising results in glioblastoma treatment, Percheron Therapeutics Ltd reported encouraging data for epilepsy, and Cyclopharm Ltd recorded it...
CSL Ltd: A Closer Look at the Biotechnology Leader
September 02, 2024 04:35 PM AEST| By Team Kalkine MediaSince the start of 2024, CSL Ltd,(ASX: CSL),has seen its share price rise by 6.0%. This growth has sparked significant interest among investors. Here’s a detailed look at why CSL shares are attracting attention and what makes this biotechnology compa...
Emyria (ASX:EMD) Sees 10% Surge on Promising Interim Results for MDMA-Assisted Therapy in PTSD Treatment
September 02, 2024 11:05 AM AEST| By Team Kalkine MediaOn Monday, shares of Emyria (ASX:EMD) experienced a notable 9.4% increase, reaching 3.5 cents per share, following the announcement of positive interim results from their MDMA-assisted psychotherapy trials for PTSD patients.,The interim data revealed...
Private Hospitals Face Increasing Challenges Amid Financial and Operational Pressures
September 02, 2024 09:58 AM AEST| By Team Kalkine MediaRecent findings by the Health Department have raised concerns over the viability of private hospitals in Australia, highlighting a potential crisis within the,healthcare sector.,The review, led by Health Department Secretary Blair Comley, points to a...
Ramsay Health Falls Short of Investor Expectations as Rising Costs Impact Margins
August 30, 2024 02:16 PM AEST| By Team Kalkine MediaRamsay Health Care Ltd,(ASX: RHC),, Australia’s largest private hospital operator, has revealed significant challenges in its latest financial update. The company is set to demand increased funding from insurers if wage growth surpasses expectations,...
Advertise your brand on Kalkine Media